Jacob Fuglsbjrg Jeppesen

Company: Novo Nordisk

Job title: Vice President

Seminars:

Panel Discussion: Interrogating in vivo & in vitro Preclinical Models to Understand Pathophysiology & Screen Targets 9:30 am

Debating the best model: recapitulating complex biology and comorbidities to test therapeutic efficacy Tailoring disease models with patient-specific characteristics to execute precision medicine From research to therapeutic application: bridging the translational gapRead more

day: Day Two

Holistic Approaches to Cardiometabolic Disease: Common Disease Pathology, Comorbidities & Combination Therapies 8:30 am

Unlocking next-generation incretin-based therapies as disease-modifying therapies Human-centric approaches to drug development: how do we approach the holistic patient view in cardiometabolic disease from a pre-clinical perspectives in the future? Two sides of the same coin: navigating holistic approaches to metabolic syndrome to redefine T2D treatmentRead more

day: Day Two